Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Multiple Myeloma Trial in Patients With Bone Metastases

ClinicalTrials.gov ID: NCT00104104

Public ClinicalTrials.gov record NCT00104104. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 2:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter,Open Label, Randomized Trial Evaluating the Duration of Infusion of Zoledronic Acid 4 mg IV in Multiple Myeloma Patients With Bone Metastases

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to study the safety of treating patients with multiple myeloma and at least one bone lesion with zoledronic acid 4mg intravenously (IV) every 3 - 4 weeks for 2 years. Patients will receive a zoledronic acid infusion for 15 minutes or 30 minutes.

Study identification

NCT ID
NCT00104104
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
179 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2004 (Type not available)
Primary completion
Oct 2007 (Actual)
Completion
Oct 2007 (Actual)
Last update posted
Jun 29, 2011

2004 – 2007

United States locations

U.S. sites
68
U.S. states
29
U.S. cities
64
Facility City State ZIP Site status
Hematology Oncology Specialists Huntsville Alabama 35801 —
Palo Verde Hematology Oncology Glendale Arizona 85304 —
US Oncology Tucson Arizona 85710 —
Myeloma Institute For Research Therapy Little Rock Arkansas 72205 —
University of Arkansas Little Rock Arkansas 72205 —
Pacific Cancer Medical Center Anaheim California 92801 —
Comprehensive Blood and Cancer Center Bakersfield California 93309 —
Southbay Oncology Hematology Partners Campbell California 95008 —
Bay Area Cancer Research Group Concord California 94520 —
California Oncology of the Central Valley Fresno California 93710 —
Dr. Robert P. Brouillard Inc. La Jolla California 92037 —
Antelope Valley Cancer Center Lancaster California 93534 —
Pacific Shores Medical Group Long Beach California 90813 —
North Valley H/O Mission Hills California 91345 —
Hematology/Oncology Group of Orange County Orange California 92868 —
Desert Hematology Oncology Medical Group Rancho Mirage California 92270 —
Camino Medical Group Sunnyvale California 94086 —
Oncotherapeutics West Hollywood California 90069 —
Greeley Medical Center Greeley Colorado 80631 —
Florida Cancer Specialists Fort Meyers Florida 33901 —
South Florida Oncology Hematology Hollywood Florida 33021 —
Osceola Cancer Center Kissimmee Florida 34741 —
Miami Cancer Care Miami Florida 33133 —
Pasco Hernado Oncology New Port Richey Florida 34652 —
MetCare Oncology Ormond Beach Florida 32174 —
Hematology Oncology Associates PA Pensacola Florida 32501 —
Hem/Onc Associates of Central Brevard Rockledge Florida 32955 —
Augusta Oncology Associates Augusta Georgia 30901 —
Georgia Cancer Specialists Tucker Georgia 30084 —
Cancer Care Center New Albany Indiana 47150 —
Hutchinson Clinic, PA Hutchinson Kansas 67502 —
Hematology and Oncology Specialists New Orleans Louisiana 70115 —
Maine Center for Cancer Medicine - Blood Disorders Scarborough Maine 04074 —
Center for Cancer and Blood Disorders Bethesda Maryland 20817 —
Oncology Hematology Associates, PA Clinton Maryland 20735 —
Maryland Oncology-Hematology PA Columbia Maryland 21044 —
Hematology Oncology Associates of Ohio & Michigan Lambertville Michigan 48144 —
Providence Cancer Center, Clinical Trials Dept Southfield Michigan 48075 —
Kansas City Cancer Center Kansas City Missouri 64131 —
St. Joseph Oncology, Inc. Saint Joseph Missouri 64507 —
The Center for Cancer Care and Research St Louis Missouri 63141 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89109 —
Nevada Cancer Center Las Vegas Nevada 89128 —
Center for Cancer & Hematology Disease Cherry Hill New Jersey 08003 —
Central Jersey Oncology Center East Brunswick New Jersey 08816 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
CINJ at Cooper University Hospital Voorhees Township New Jersey 08043 —
New Mexico Cancer Care Associates Santa Fe New Mexico 87505 —
Hematology Oncology of Western Suffolk Bay Shore New York 11706 —
New York Presbyterian Hospital New York New York 10021 —
Syracuse Hematology/Oncology PC Syracuse New York 13210 —
Dayton Oncology & Hematology, PA Kettering Ohio 45409 —
University of Pennsylvania, Philadelphia Philadelphia Pennsylvania 19104 —
Pennsylvania Oncology Associates Philadelphia Pennsylvania 19106 —
Berks Oncology and Hematology Associates West Reading Pennsylvania 19611 —
Hematology & Oncology Associates of RI Cranston Rhode Island 02920 —
Roger Williams Hospital Medical Center Providence Rhode Island 02908 —
Charleston Hematology Oncology Charleston South Carolina 29403 —
Baptist Regional Cancer Center Knoxville Tennessee 37920 —
Center for Oncology Research & Treatment, PA Dallas Texas 75230 —
UT Southwestern Medical Center Dallas Texas 75390-9179 —
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410 —
Utah Hematology Oncology Ogden Utah 84403 —
Oncology Hematology Associates of Southwest VA Salem Virginia 24153 —
Western Washington Oncology Lacey Washington 98503 —
Swedish Cancer Institute Seattle Washington 98104 —
Fox Valley Hematology Oncology SC Appleton Wisconsin 54915 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00104104, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 29, 2011 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00104104 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →